Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.639
-0.034 (-4.98%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Impact BioMedical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 67 | 17 | - | - | - | - | |
| Enterprise Value | 90 | 25 | - | - | - | - | |
| Last Close Price | 0.64 | 1.45 | - | - | - | - | |
| PB Ratio | - | 2.31 | - | - | - | - | |
| Debt / Equity Ratio | -2.58 | 1.23 | 0.43 | 0.31 | 0.31 | 0.03 | |
| Net Debt / Equity Ratio | -2.58 | 0.95 | 0.43 | 0.31 | 0.31 | 0.02 | |
| Net Debt / EBITDA Ratio | -7.32 | -2.03 | -3.00 | -4.36 | -6.02 | - | |
| Net Debt / FCF Ratio | -5.66 | -1.75 | -4.21 | -3.97 | -6.16 | -1.10 | |
| Asset Turnover | 0.00 | - | - | 0.00 | - | - | |
| Quick Ratio | 0.00 | 0.20 | 0.01 | 0 | 0.00 | 0.07 | |
| Current Ratio | 0.04 | 0.25 | 0.03 | 0.01 | 0.02 | 0.10 | |
| Return on Equity (ROE) | -346.99% | -139.55% | -14.46% | -19.99% | -4.52% | -3.89% | |
| Return on Assets (ROA) | -7.68% | -6.54% | -5.53% | -4.13% | -3.81% | -2.32% | |
| Return on Capital Employed (ROCE) | 71.40% | -32.30% | -12.80% | -9.50% | -7.30% | -1.90% | |
| Earnings Yield | -66.11% | -148.12% | - | - | - | - | |
| FCF Yield | -6.04% | -23.49% | - | - | - | - | |
| Buyback Yield / Dilution | 80.23% | 82.14% | 14.54% | 0.00% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.